Testimony on The Reauthorization of the Prescription Drug User Fee Act for Fiscal Years 2008 to 2012
Release Date:
February 16, 2007
On: Proposed Recommendations for The Reauthorization of the Prescription Drug User Fee Act for Fiscal Years 2008 to 2012 ("PDUFA IV")
To: The Food and Drug Administration
By: Anthony C. Wisniewski, Executive Director of Health Care Policy, U.S. Chamber of Commerce
Date: February 16, 2007
View Testimony (PDF)
Related Links
- National Sign-On Letter to Repeal the 1099 Provision in the Health Care Law
- Comments on Interim Final Rules for Pre-Existing Condition Insurance Plan Program
- Caroline L. Harris
- Comments to HHS on Insurance and Rating Rules Extension Request
- Guidance on 90-day Waiting Period Limitation (DOL Technical Release 2012-02)
- Comments on Institute of Medicine of the National Academies Survey on Essential Health Benefits
- National Sign-on Letter Urging Congress to Repeal Section 9006 of the "Patient Protection and Affordable Care Act"
- Comments to HHS on Reinsurance Rule Extension Request